279885 20260107151229.0 EP-2878677-A1 EP2878677A1 Patent DZNE-2025-00852 Groll, Michael P:(DE-HGF)0 0 Activators of protein phosphatase 5 2015 PATENT ORCID Patent patent patent PUB:(DE-HGF)23 1752572536_17592 PUB:(DE-HGF) patent DRIVER TECHREPORT BibTeX Patent 15 EndNote Patent DataCite The present invention relates to compounds that show a positive result in a phosphatase activation assay with protein phosphatase 5 according to the invention, to compounds that bind in an in vitro binding assay to a certain region of the amino acid sequence of protein phosphatase 5, as well as to compounds that show a positive result in a phosphatase activation assay with protein phosphatase 5 according to the invention and bind in an in vitro binding assay to a certain region of the amino acid sequence of protein phosphatase 5. The present invention also relates to pharmaceutical compositions comprising one or more of such compounds, to methods of using such a compound, and to methods of screening for compounds that activate protein phosphatase 5. 899 - ohne Topic (POF4-899) G:(DE-HGF)POF4-899 POF4-899 POF IV 0 Richter, Klaus P:(DE-HGF)0 1 Haslbeck, Veronika P:(DE-HGF)0 2 Striggow, Frank P:(DE-2719)9000420 3 Martin, Helmuth P:(DE-HGF)0 4 Schmidt, Werner P:(DE-2719)9000421 5 Weiwad, Matthias P:(DE-HGF)0 6 Fischer, Gunter P:(DE-HGF)0 7 http://pub.dzne.de/record/279885/files/DZNE-2025-00852_Restricted.pdf http://pub.dzne.de/record/279885/files/DZNE-2025-00852_Restricted.pdf?subformat=pdfa pdfa oai:pub.dzne.de:279885 VDB Deutsches Zentrum für Neurodegenerative Erkrankungen I:(DE-588)1065079516 DZNE 3 P:(DE-2719)9000420 Deutsches Zentrum für Neurodegenerative Erkrankungen I:(DE-588)1065079516 DZNE 5 P:(DE-2719)9000421 DE-HGF Programmungebundene Forschung ohne Programm G:(DE-HGF)POF4-890 G:(DE-HGF)POF4-899 G:(DE-HGF)POF4 G:(DE-HGF)POF4-800 G:(DE-HGF)POF ohne Topic 0 2015 I:(DE-2719)5000045 AG Striggow Neurodegeneration and Intervention Strategies 0 patent VDB I:(DE-2719)5000045 UNRESTRICTED